Where: Bldg. 40, Conference Room 1201/1203
When: Thursday, March 21st 2024, 3:00pm
Seminar: Altered Ubiquitin Signaling and Alzheimer’s Disease
Speaker: Michael H. Glickman, Ph.D.
Virtual Attendance via Microsoft Teams: https://events.gcc.teams.microsoft.com/event/46cd8f0d-a4c0-4f6f-93df-8687301ec4c2@14b77578-9773-42d5-8507-251ca2dc2b06
About the Speaker:
Michael H. Glickman is a Full Professor and current Dean at Department of Biology, Technion-Israel Institute of Technology, one of the top universities in Israel. He acquired his bachelor’s degree in Chemistry from The Hebrew University of Jerusalem with top honors in 1989 and Ph.D. from University of California Berkeley with Prof. Judith Klinman in 1994. He worked on the studies of ubiquitin-proteasome proteolysis system as a postdoctoral scholar with Prof. Daniel Finley at the Harvard Medical School, where he identified the regulatory subcomplex of proteasome, a milestone in the complex field of proteasome research.
Since establishing his lab at Technion in 1999, he has been carrying out outstanding research projects not only on the proteasome complex but on ubiquitin-related neurological diseases as well. His recent research "Altered ubiquitin signaling and Alzheimer's Disease" was highlighted by Alzforum as “a major achievement” Could a Faulty Ubiquitin Trigger Amyloid and Tau Deposits? | ALZFORUM and by the AAAS EurekAlert! As a “Breakthrough in understanding the onset of sporadic Alzheimer's disease” https://www.eurekalert.org/news-releases/1003532 .